Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma with colon involvement. 2015

Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita

UI MeSH Term Description Entries
D007085 Ilium The largest of three bones that make up each half of the pelvic girdle. Auricular Surface of Ilium,Iliac Crest,Iliac Crest Bone,Iliac Fossa,Bones, Iliac Crest,Crest Bone, Iliac,Crest Bones, Iliac,Crest, Iliac,Crests, Iliac,Fossa, Iliac,Iliac Crest Bones,Iliac Crests,Iliums
D008297 Male Males
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003113 Colonoscopy Endoscopic examination, therapy or surgery of the luminal surface of the colon. Colonoscopic Surgical Procedures,Surgical Procedures, Colonoscopic,Colonoscopic Surgery,Surgery, Colonoscopic,Colonoscopic Surgeries,Colonoscopic Surgical Procedure,Colonoscopies,Procedure, Colonoscopic Surgical,Procedures, Colonoscopic Surgical,Surgeries, Colonoscopic,Surgical Procedure, Colonoscopic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077548 Anaplastic Lymphoma Kinase A receptor tyrosine kinase that is essential for development and differentiation of the nervous system in response to secreted growth factors. It phosphorylates the first tyrosine of the Y-x-x-x-Y-Y motif of targets that include PROTO-ONCOGENE PROTEINS C-CBL; INSULIN RECEPTOR SUBSTRATE-1; and MITOGEN-ACTIVATED PROTEIN KINASES, leading to activation of the MAPK signaling pathway and cell proliferation. A chromosomal aberration involving the ALK gene results in its constitutive expression in some cases of NON-HODGKIN LYMPHOMA. ALK Kinase,ALK Tyrosine Kinase Receptor,Anaplastic Lymphoma Receptor Tyrosine Kinase,CD246 Antigen,NPM-ALK,Nucleophosmin-Anaplastic Lymphoma Kinase,Nucleophosmin Anaplastic Lymphoma Kinase
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017728 Lymphoma, Large-Cell, Anaplastic A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS. Anaplastic Large-Cell Lymphoma,CD30-Positive Anaplastic Large-Cell Lymphoma,Lymphoma, Large-Cell, Ki-1,CD30+ Anaplastic Large-Cell Lymphoma,Ki-1 Lymphoma,Systemic Anaplastic Large-Cell Lymphoma,Anaplastic Large Cell Lymphoma,Anaplastic Large-Cell Lymphomas,CD30 Positive Anaplastic Large Cell Lymphoma,CD30+ Anaplastic Large Cell Lymphoma,Ki 1 Lymphoma,Ki-1 Lymphomas,Large-Cell Lymphoma, Anaplastic,Large-Cell Lymphomas, Anaplastic,Lymphoma, Anaplastic Large-Cell,Lymphoma, Ki-1,Lymphomas, Anaplastic Large-Cell,Lymphomas, Ki-1,Systemic Anaplastic Large Cell Lymphoma

Related Publications

Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
February 2021, The Journal of dermatology,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
December 2015, Histopathology,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
January 2016, OncoTargets and therapy,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
January 2021, British journal of haematology,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
January 2014, Journal of medical case reports,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
March 2012, The Korean journal of hematology,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
April 2016, Cancer genetics,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
May 2005, Human pathology,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
January 2024, AME case reports,
Yuko Sakakibara, and Shoichi Nakazuru, and Takuya Yamada, and Tetsuya Iwasaki, and Ryuichiro Iwasaki, and Akio Ishihara, and Kumiko Nishio, and Hisashi Ishida, and Yoshinori Kodama, and Eiji Mita
December 2021, Diagnostic cytopathology,
Copied contents to your clipboard!